Budget Office Savings Estimates For Follow-On Biologics May Be Modest – McClellan
This article was originally published in The Pink Sheet Daily
Executive Summary
Follow-on biologics savings estimates by the Congressional Budget Office could “take some wind out of the sails” to develop legislation, the former FDA commissioner says.